At a Glance
| Diclazepam | Carisoprodol | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 1–3 mg | 325–500 mg |
| Total Duration | 0.2–0.8 hrs | 2.3–6 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Diclazepam and Carisoprodol is classified as dangerous. Combined CNS depression; risk of respiratory failure
Diclazepam, a Depressant, and Carisoprodol, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 12 documented effects in common, with 4 effects unique to Diclazepam and 12 unique to Carisoprodol. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Diclazepam | Carisoprodol | |
|---|---|---|
| Class | Depressant | Depressant |
| Common Dose (oral) | 1–3 mg | 325–500 mg |
| Total Duration | 0.2–0.8 hrs | 2.3–6 hrs |
| Routes | oral | oral |
| Effects |
| 16 documented |
| 24 documented |
| Interaction | Dangerous | |
| Level | Diclazepam | Carisoprodol |
|---|---|---|
| Threshold | 0.5 mg | 50 mg |
| Light | 0.5–1 mg | 100–325 mg |
| Common | 1–3 mg | 325–500 mg |
| Strong | 3–4 mg | 500–750 mg |
| Heavy | 4 mg | 750 mg |
Diclazepam
Carisoprodol
Combined CNS depression; risk of respiratory failure